Killian, Tobias
Dickopf, Steffen
Haas, Alexander K.
Kirstenpfad, Claudia
Mayer, Klaus
Brinkmann, Ulrich
Article History
Received: 6 March 2017
Accepted: 24 October 2017
First Online: 13 November 2017
Competing Interests
: The authors are employed by Roche Pharma Research and Early Development. Roche is interested in targeted therapies.